Skip to Content
Home > About Us > Research and Grants Administration > Detail
<< Back to Results
To compare the effectiveness of standard chemotherapy regimens (Cyclophosphamide, Methotrexate and Fluorouracil [CMF] or Doxorubicin and Cyclophosphamide [AC]) with single agent Capecitabine with respect to disease-free survival in women 65 years and older with local and regional breast cancer.
View Additional Section Content
For more information about our research program and IRB, please contact: